Andrew Thorley

Andrew Thorley

Company: Genentech

Job title: Fibrosis Therapeutic Area Lead - OMNI Biomarker Development


Providing an Update on IPF Biomarkers: Uncovering the Emerging Consensus on Which Biomarker Best Predicts Disease Progression to Help Maximize the Success of Your ILD Therapeutic in a Clinical Setting 9:30 am

Reviewing findings from previous clinical trials Emerging biological and digital biomarkers Health equity in biomarker developmentRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.